GlassScriptPhysician profile
Demi M Turner
NPI 1487812376
$10,051.48
in general payments reported to CMS, 2019-2025
14 companies · $284 in 2025
The $284 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,349 · 2020: $59.65 · 2021: $290 · 2022: $466 · 2023: $240 · 2024: $363 · 2025: $284.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $887.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $887.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $8,818.95 | 2019-2023 | Krystexxa |
| Amgen INC. | $386.17 | 2024-2025 | Krystexxa |
| Paratek Pharmaceuticals, INC. | $177.82 | 2022-2025 | Nuzyra |
| Ani Pharmaceuticals, INC. | $165.80 | 2023-2025 | Purified Cortrophin Gel |
| Alfasigma USA, INC. | $132.13 | 2020-2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $119.81 | 2022 | |
| Stryker Corporation | $86.58 | 2019-2024 | Augment Injectable, Lpt |
| Sebela Pharmaceuticals INC. | $43.84 | 2019-2020 | |
| Smith+Nephew, INC. | $40.10 | 2019-2020 | |
| Treace Medical Concepts, INC. | $18.22 | 2022 | |
| Convatec INC. | $17.29 | 2024 | |
| Integra Lifesciences Corporation | $16.97 | 2019 | |
| Abbott Laboratories | $14.20 | 2024 | Eterna |
| Medtronic, INC. | $13.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Demi Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.